Article thumbnail

A protocol to assess cell cycle and apoptosis in human and mouse pluripotent cells

By Michael J Edel, Cristina Menchon, Jose Miguel Andres Vaquero and Juan Carlos Izpisua Belmonte


Embryonic stem cells (ESC) and induced pluripotent stem cells (iPSCs) present a great opportunity to treat and model human disease as a cell replacement therapy. There is a growing pressure to understand better the signal transduction pathways regulating pluripotency and self-renewal of these special cells in order to deliver a safe and reliable cell based therapy in the near future. Many signal transduction pathways converge on two major cell functions associated with self-renewal and pluripotency: control of the cell cycle and apoptosis, although a standard method is lacking across the field. Here we present a detailed protocol to assess the cell cycle and apoptosis of ESC and iPSCs as a single reference point offering an easy to use standard approach across the field

Topics: Methodology
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2002). Analysis of the cell cycle in mouse embryonic stem cells. Methods Mol Biol
  2. (2009). Blasco MA: A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature
  3. (2005). Cell cycle control of embryonic stem cells. Stem Cell Rev
  4. (2009). Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell
  5. (2006). GS: Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase.
  6. (2009). Hochedlinger K: Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature
  7. (2010). Izpisua Belmonte JC: A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells. Nat Protoc
  8. (2010). Izpisua Belmonte JC: Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1. Genes Dev
  9. (1998). JM: Embryonic stem cell lines derived from human blastocysts. Science
  10. (2009). Krishan A: Click-iT assay with improved DNA distribution histograms. Cytometry A
  11. (2009). Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature
  12. (2002). Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene
  13. (2006). Production and purification of lentiviral vectors. Nat Protoc
  14. (2004). S: Cdk6-cyclin D3 activity in murine ES cells is resistant to inhibition by p16(INK4a). Oncogene
  15. (2009). The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature
  16. (2008). Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell
  17. (2007). Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell
  18. (2006). Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell
  19. (2009). Yamanaka S: Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature